Industry News
-
Tetraneuron Secures Funding to Advance First-in-Class AAV Gene Therapy for Alzheimer’s disease
Dec 11 2025 -
FDA Approves First LVV-based Gene Therapy for Wiskott-Aldrich Syndrome
Dec 10 2025 -
Diakonos Oncology Secures $7M CPRIT Grant to Advance Personalized Dendritic Cell Vaccine for Refractory Melanoma
Dec 10 2025 -
Strategic Focus Drives Evolution in Cell and Gene Therapy Funding Landscape
Dec 10 2025 -
FDA Set to Require Randomized Trials and Superiority Data for Full CAR T Approval
Dec 09 2025 -
Japan Grants Pioneering AAV Gene Therapy Designations to AskBio for Parkinson’s and Heart Failure Programs
Dec 09 2025 -
Kelonia’s In Vivo CAR-T Therapy KLN-1010 Achieves 100% MRD-Negative Responses in Early Multiple Myeloma Data
Dec 09 2025 -
Gene Therapy Upstart EpilepsyGTx Secures $33 Million Series A to Advance AAV-Based Epilepsy Program
Dec 09 2025 -
FDA Approves Bristol Myers Squibb’s CAR T-Cell Therapy for Relapsed/Refractory Marginal Zone Lymphoma
Dec 09 2025